Turn Therapeutics (TTRX) Change in Cash (2024 - 2026)

Turn Therapeutics has reported Change in Cash for 3 years, with the latest figure at $6.1 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash rose 777.32% year-over-year to $6.1 million; the trailing twelve-month figure through Mar 2026 stood at $8.9 million (changed N/A YoY), and the FY2025 full-year result was $4.2 million, up 1463.03% from the prior year.
• Change in Cash for Q1 2026 stood at $6.1 million, up from $2.0 million in the prior quarter.
• The five-year high for Change in Cash was $6.1 million in Q1 2026, with the low at $83819.0 in Q4 2024.
• Average Change in Cash over 3 years is $2.2 million, with a median of $1.3 million recorded in 2025.
• Year-over-year, Change in Cash surged 2250.29% in 2025 and surged 777.32% in 2026.
• Tracing TTRX's Change in Cash over 3 years: stood at $83819.0 in 2024, then surged by 2250.29% to $2.0 million in 2025, then jumped by 211.75% to $6.1 million in 2026.
• The last three Change in Cash figures came in at $6.1 million (Q1 2026), $2.0 million (Q4 2025), and $700034.0 (Q1 2025), per Business Quant data.

Peer Comparison